Use of Decision Aids in Clinical Encounters

May 23, 2016 updated by: Victor Montori, Mayo Clinic

Patient-centered Dissemination of Evidence-based Medicine: Share EBM

The active strategy for dissemination and implementation of Share Evidence Based Medicine (EBM) will yield greater reach of clinicians, be adopted by the practices more readily, and a greater uptake of use amongst encounters will be seen.

The Institute for Clinical Systems Improvement (ICSI) is a nonprofit organization with expertise in large-scale practice improvement at the state and national level. Largely funded by health organizations in Minnesota, ICSI has a sustainable model to translate evidence into practice, through clinical practice guidelines, shared decision making, and practice redesign. A partnership between these two organizations (ICSI and Mayo Clinic) may lead to a sustainable and innovative approach to the dissemination of evidence-based health information at the point of care.

The objective of the current study is therefore to leverage the expertise of these two organizations to compare the impact of an active to a passive dissemination and implementation strategy of the ShareEBM toolkit. The aim of the study is to disseminate evidence-based information through the use of decision aids during encounters. The overall purpose of the qualitative evaluation is to understand why decision aids were used more or less in certain practices and what factors contributed to or hindered this uptake.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Brooklyn Center, Minnesota, United States, 55430
        • Park Nicollet- Brookdale
      • Delano, Minnesota, United States, 55328
        • Ridgeview Medical Center
      • Duluth, Minnesota, United States, 55804
        • Essentia Health-Lakeside Clinic
      • Eagan, Minnesota, United States, 55122
        • Fairview Clinic-Eagan
      • Golden Valley, Minnesota, United States, 55427
        • Park Nicollet-Golden Valley
      • Hermantown, Minnesota, United States, 55811
        • Essentia Hermantown Clinic
      • Minneapolis, Minnesota, United States, 55404
        • Native American Community Clinic
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic
      • Rochester, Minnesota, United States, 55904
        • Community Health Service, Inc.
      • Rosemount, Minnesota, United States, 55068
        • Fairview Medical-Rosemount
    • Wisconsin
      • Baldwin, Wisconsin, United States, 54002
        • Baldwin Area Medical Center, Inc.
      • Hudson, Wisconsin, United States, 54016
        • Hudson Physicians S.C.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Practices meeting the following criteria will be deemed eligible for the study if they have:

    1. At least 2 primary care clinicians committed to participate in the study. Clinicians are defined as any healthcare professional providing patient care (i.e., physicians, nurse practitioners, physician assistants, diabetes educators)
    2. A designated site champion and support staff that can provide the support needed to conduct the study
    3. An IRB approval from their institution or are covered under Mayo Clinic IRB
    4. Leadership is committed to this research and has endorsed the study
  • Any clinician caring for patients with a chronic condition and who has opportunities to discuss medication management with their patients will be deemed eligible

Exclusion Criteria:

  • Major barriers to participating or to providing informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Active Implementation of Share EBM Toolkit
Investigators led implementation of tailored activities and tactics (Shared EBM Toolkit) designed to promote the use of the decision aids in clinical encounters (i.e. journal clubs, value map streaming).
Other: Active Implementation of ShareEBM Toolkit
Other: Passive Implementation of Share EBM Toolkit
Locally supported dissemination of Shared EBM Toolkit designed to promote the use of the decision aids in clinical encounters.
Other: Passive Dissemination of Share EBM

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Frequency of use of decision aids in clinical encounters by weekly reports
Time Frame: up to 1 year
up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mayo Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

March 24, 2014

First Submitted That Met QC Criteria

May 8, 2014

First Posted (Estimate)

May 12, 2014

Study Record Updates

Last Update Posted (Estimate)

May 24, 2016

Last Update Submitted That Met QC Criteria

May 23, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 14-002055

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes, Depression, Cardiovascular Disease,Hypercholesterolemia, Osteoporosis

Clinical Trials on Active Implementation of ShareEBM Toolkit

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe